Yestar Healthcare Holdings Co (HKSE:02393) ROCE % : 915.97% (As of Jun. 2024)

View and export this data going back to 2013. Start your Free Trial

What is Yestar Healthcare Holdings Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Yestar Healthcare Holdings Co's annualized ROCE % for the quarter that ended in Jun. 2024 was 915.97%.

Yestar Healthcare Holdings Co ROCE % Historical Data

The historical data trend for Yestar Healthcare Holdings Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Yestar Healthcare Holdings Co ROCE % Chart

Yestar Healthcare Holdings Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

16.50

-25.86

10.09

-16.94

Yestar Healthcare Holdings Co Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
ROCE %	Get a 7-Day Free Trial															-8.96	-19.60	-	-	915.97

Yestar Healthcare Holdings Co ROCE % Calculation

Yestar Healthcare Holdings Co's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	225.044	/	( ( (3762.932 - 3908.26)	+	(3747.491 - 4070.379) )	/ 2 )
	=	225.044	/	( (-145.328	+	-322.888)	/ 2 )
	=	225.044	/	-234.108
	=	-96.13 %

Yestar Healthcare Holdings Co's ROCE % of for the quarter that ended in Jun. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Jun. 2024 )		(Q: Dec. 2023 )		(Q: Jun. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Jun. 2024 )		(Q: Dec. 2023 )		(Q: Jun. 2024 )
	=	2440.66	/	( ( (3747.491 - 4070.379)	+	(1979.507 - 1123.709) )	/ 2 )
	=	2440.66	/	( ( -322.888	+	855.798 )	/ 2 )
	=	2440.66	/	266.455
	=	915.97 %

(1) Note: The EBIT data used here is two times the semi-annual (Jun. 2024) EBIT data.

Yestar Healthcare Holdings Co (HKSE:02393) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Yestar Healthcare Holdings Co ROCE % Related Terms

Thank you for viewing the detailed overview of Yestar Healthcare Holdings Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Yestar Healthcare Holdings Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Yestar Healthcare Holdings Co Ltd (HKSE:02393) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 58 Shen Jian Dong Lu, Room 805, Block 2, Min Hang District, Shanghai, CHN

Website

http://www.yestarcorp.com

Yestar Healthcare Holdings Co Ltd is engaged in the manufacturing, distribution and sale of medical imaging products, distribution of In Vitro Diagnostic products and the manufacturing and sale of dental films. The company has two segments namely Imaging printing products and Medical products and equipment. The group operates its business in Mainland China.

Executives

Hartono James	2101 Beneficial owner
Ubs Group Ag	2201 Interest of corporation controlled by you
Fok Hei Yu (in The Capacity As The Receiver)	2501 Other
Chow Wai Shing Daniel (in The Capacity As The Receiver)	2501 Other
Li Bin	2101 Beneficial owner
Hartono Jeane
Hartono Rico
Fujifilm Corporation	2101 Beneficial owner
Fujifilm Holdings Corporation	2201 Interest of corporation controlled by you

Yestar Healthcare Holdings Co Headlines

No Headlines